EUVIMEDEUVIMED entdecken
Open Access

Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation

John C Stendahl iD, Sounok Sen iD, Michael Butzner, Eros Papademetriou, Ravi Potluri iD, Xing Liu, Daniel Jacoby, James V Freeman iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.038755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von John C Stendahl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine Yale School of Medicine New Haven CT USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Health Care Costs, Cost of Illness. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is common among patients with obstructive hypertrophic cardiomyopathy (oHCM), although the impact of AF on health care resource use and costs is not well defined.

Methods

We performed a retrospective analysis of claims data from 2016 to 2021 and used International Classification of Diseases, Tenth Revision ( ICD‐10 ) codes to identify adult patients with symptomatic oHCM and classify their status with respect to AF as follows: (1) prevalent AF, (2) incident AF, and (3) no AF. Health care resource use and costs for each cohort were analyzed and expressed as per person per year (PPPY).

Results

Of 22 216 patients with symptomatic oHCM, 6677 had prevalent AF (30.1%), 2879 had incident AF (13.0%), and 12 660 were without AF (57.0%). Patients with incident AF incurred mean total health care costs that were similar to those with prevalent AF but substantially greater than those without AF (mean, $66 619 [95% CI, $59 702–$74 336] versus $63 937 [95% CI, $59 803–$68 356] versus $46 686 [95% CI, $43 901–$49 648] per person per year, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathy, HypertrophicHealth Care CostsCost of IllnessHealth ResourcesHumansMaleFemaleRetrospective StudiesMiddle AgedAgedUnited StatesPrevalenceIncidenceAdultHospitalization

Stichwörter der Autor:innen

atrial fibrillationhealth care costshealth care resource usehypertrophic cardiomyopathyobstructive hypertrophic cardiomyopathy

Autor:innen und Institutionen

  • Section of Cardiovascular Medicine Yale School of Medicine New Haven CT USA.
  • Cytokinetics Incorporated South San Francisco CA USA.
  • Putnam Associates, LLC Boston MA USA.

ORCID-Profile: John C Stendahl, Sounok Sen, Ravi Potluri, James V Freeman

Zitieren

APA

Stendahl, J. C., Sen, S., Butzner, M., Papademetriou, E., Potluri, R., Liu, X., Jacoby, D., & Freeman, J. V. (2025). Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038755

Vancouver

Stendahl JC, Sen S, Butzner M, Papademetriou E, Potluri R, Liu X, et al. Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038755

BibTeX
@article{Stendahl2025,
  author = {Stendahl, John C and Sen, Sounok and Butzner, Michael and Papademetriou, Eros and Potluri, Ravi and Liu, Xing and Jacoby, Daniel and Freeman, James V},
  title = {Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.038755}
}
Kostenlos starten →